Claro Scientific is developing SpectraWave™, an innovative, reagentless diagnostic system platform using its patented multidimensional optical profiling technology. Claro’s proprietary software and database system, SpectraNet™, interprets this data to deliver highly precise, detailed and quantitative information about the composition and character of biologic and non-biologic samples in less than 5 minutes. SpectraWave and SpectraNet have significant competitive advantages in several commercial markets including protein characterization, cellular analysis, biotechnology process development and research, medical diagnostics, personalized health monitoring, blood banking, biodefense, environmental monitoring, agriculture, food safety and veterinary medicine. Each commercial application leverages a core hardware platform, application software and optical profile databases.